TERBINAFINE HYDROCHLORIDE ![]() (ter-bin'a-feen) ![]() Lamisil, Lamisil DermaGel Classifications: antibiotic; allylamine antifungal; Therapeutic: antibiotic; antifungal Pregnancy Category: B |
250 mg tablets; 1% cream; 1.12% gel
Synthetic antifungal agent that inhibits sterol biosynthesis in fungi and ultimately causes fungal cell death.
Effective as a topical antifungal treatment as well as in oral form.
Topical treatment of superficial mycoses such as interdigital tinea pedis, tinea cruris, and tinea corporis due to Epidermophyton floccosum, Trichophyton mentagrophytes, or T. rubrum; oral treatment of onychomycosis due to tinea unguium.
Hypersensitivity to terbinafine; alcoholism; hepatic disease; hepatitis; jaundice; renal impairment; renal failure; lactation.
Pregnancy (category B). Safety and efficacy in children <12 y are not established.
Tinea Pedis, Tinea Cruris, or Tinea Corporis Adult: Topical Apply q.d. or b.i.d. to affected and immediately surrounding areas until clinical signs and symptoms are significantly improved (17 wk) Onychomycosis Adult: PO 250 mg q.d. x 6 wk for fingernails or x 12 wk for toenails |
Assessment & Drug Effects
Patient & Family Education